MiR-199 Reverses the Resistance to Gemcitabine in Pancreatic Cancer by Suppressing Stemness through Regulating the Epithelial–Mesenchymal Transition

[Image: see text] Purpose: the present study aims to investigate the function of miR-199 on gemcitabine (GEM)-resistance in pancreatic cancer, as well as the underlying mechanism. Methods: the GEM-resistant SW1990 cell line (SW1990/SZ) was established. The CCK-8 assay was used to detect the cell via...

Descripción completa

Detalles Bibliográficos
Autores principales: Wei, Weitian, Wang, Liang, Xu, Liwei, Liang, Jinxiao, Teng, Lisong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Chemical Society 2021
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8637594/
https://www.ncbi.nlm.nih.gov/pubmed/34869970
http://dx.doi.org/10.1021/acsomega.1c02945

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8637594/
https://www.ncbi.nlm.nih.gov/pubmed/34869970
http://dx.doi.org/10.1021/acsomega.1c02945

Ejemplares similares